MRC1 and Lynch syndrome: However, universal MMR-immunohistochemistry is somewhat limited in that it only applies to a single hereditary cancer predisposition syndrome (Lynch syndrome) among the dozens of hereditary cancer conditions which are now routinely diagnosed in the clinical setting.